đź“‹ FDA Reference

orthopaedic innovations renewal acetabular cup system

Orthopaedic Innovations

Summary: The Renewal Acetabular Cup System is an orthopedic implant used in hip replacement surgeries. It is primarily utilized by orthopedic surgeons to restore joint function in patients with hip joint degeneration.

FDA Clearance Information

Pathway 510K
Decision Date April 15, 2002
Product Code LPH
Device Class Class 2
Evidence 10 studies

The Renewal Acetabular Cup System by Orthopaedic Innovations was cleared through the FDA 510k pathway on April 15, 2002. It is classified as a Class 2 medical device under product code LPH.

What It Is

The Renewal Acetabular Cup System is a component of hip prostheses used in total hip arthroplasty. It is designed to replace the acetabulum, the socket portion of the hip joint, in patients suffering from severe arthritis or hip fractures. The device is typically made from biocompatible materials such as metal alloys and polyethylene, allowing for durable and smooth joint articulation.

Clinical Applications

This device is commonly used in orthopedic surgical settings, particularly in total hip replacement procedures. It is indicated for patients with osteoarthritis, rheumatoid arthritis, or traumatic arthritis of the hip joint. Orthopedic surgeons utilize this system to improve mobility and reduce pain in patients, often in hospital or specialized surgical centers.

Indications for Use

The FDA indications for the Renewal Acetabular Cup System include use in patients with degenerative joint diseases affecting the hip. It is suitable for individuals requiring hip joint replacement due to arthritis or hip fractures.

Practical Considerations

The Renewal Acetabular Cup System comes in various sizes to accommodate different patient anatomies. It is compatible with other components of hip prostheses, and surgeons should consider the patient's bone quality and anatomy when selecting the appropriate size and type of cup.

Linked Studies (10)

PubMed • 2025

Innovations in peritoneal dialysis fluid: biocompatible formulations and expanded therapeutic applications.

Renal failure

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Artificial Intelligence in Valvular Heart Disease: Innovations and Future Directions.

JACC. Cardiovascular interventions

View Source →
PubMed • 2025

3D printing innovations in catheter design to reduce catheter-associated infections: a scoping review.

Journal of biomaterials science. Polymer edition

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Innovations in Psychotherapy.

Focus (American Psychiatric Publishing)

View Source →
PubMed • 2023

Improving Foley Catheter Insertion Procedure by Developing Foley Introducer: A 100-Year Overdue Innovation.

International neurourology journal

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Digital innovations for retinal care in diabetic retinopathy.

Acta diabetologica

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2020

Innovations in indwelling urethral catheterisation.

BJU international

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2017

Improvement of patient eligibility with the use of new generation endografts for the treatment of abdominal aortic aneurysms. A comparison study among currently used endografts and literature review.

Expert review of medical devices

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2014

Technical innovation in minimally invasive repair of pectus excavatum.

Pediatric surgery international

RCT|prospective|retrospective|case Series|other View Source →
ClinicalTrials.gov

Diagnostic Innovations in Glaucoma Study

View Source →

Frequently Asked Questions

What is the Renewal Acetabular Cup System used for?

It is used in total hip replacement surgeries to replace the acetabulum in patients with hip joint degeneration.

What specialties typically use this device?

Orthopedic surgeons specializing in joint replacement surgeries typically use this device.

What are the FDA-cleared indications?

The device is indicated for patients with degenerative joint diseases of the hip, such as arthritis or fractures requiring hip replacement.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.